TY - JOUR
T1 - Case Report: A Case Report of Stereotactic Ventricular Arrhythmia Radioablation (STAR) on Large Cardiac Target Volume by Highly Personalized Inter- and Intra-fractional Image Guidance
AU - Narducci, Maria Lucia
AU - Cellini, Francesco
AU - Placidi, Lorenzo
AU - Boldrini, Luca
AU - Perna, Francesco
AU - Bencardino, Gianluigi
AU - Pinnacchio, Gaetano
AU - Bertolini, Roberta
AU - Cannelli, Giorgio
AU - Frascino, Vincenzo
AU - Tagliaferri, Luca
AU - Chiesa, Silvia
AU - Mattiucci, Gian Carlo
AU - Balducci, Mario
AU - Gambacorta, Maria Antonietta
AU - Rossi, Marco
AU - Indovina, Luca
AU - Pelargonio, Gemma
AU - Valentini, Vincenzo
AU - Crea, Filippo
PY - 2020
Y1 - 2020
N2 - Introduction: Although catheter ablation is the current gold standard treatment for refractory ventricular arrhythmias, sometimes its efficacy is not optimal and it's associated with high risks of procedural complication and death. Stereotactic arrhythmia radioablation (STAR) is increasingly being adopted for such clinical presentation, considering its efficacy and safety. Case Presentation: We do report our experience managing a case of high volume of left ventricle for refractory ventricular tachycardia in advanced heart failure patient, by delivering a single fraction of STAR through an highly personalization of dose delivery applying repeated inter- and continuous intra-fraction image guidance. Conclusion: According to the literature reports, we recommend considering increasing as much as possible the personalization features and safety technical procedure as long as that is not significantly affecting the STAR duration. Moreover, the duration in itself shouldn't be the main parameter, but balanced into the frame of possibly obtainable outcome improvement. At best of our knowledge, this is the first report applying such specific technology onto this clinical setting. Future studies will clarify these issues.
AB - Introduction: Although catheter ablation is the current gold standard treatment for refractory ventricular arrhythmias, sometimes its efficacy is not optimal and it's associated with high risks of procedural complication and death. Stereotactic arrhythmia radioablation (STAR) is increasingly being adopted for such clinical presentation, considering its efficacy and safety. Case Presentation: We do report our experience managing a case of high volume of left ventricle for refractory ventricular tachycardia in advanced heart failure patient, by delivering a single fraction of STAR through an highly personalization of dose delivery applying repeated inter- and continuous intra-fraction image guidance. Conclusion: According to the literature reports, we recommend considering increasing as much as possible the personalization features and safety technical procedure as long as that is not significantly affecting the STAR duration. Moreover, the duration in itself shouldn't be the main parameter, but balanced into the frame of possibly obtainable outcome improvement. At best of our knowledge, this is the first report applying such specific technology onto this clinical setting. Future studies will clarify these issues.
KW - SBRT
KW - STAR
KW - cardiac radioablation
KW - personalized medicine
KW - radiosurgery
KW - radiotherapy
KW - ventricular arrhythmia
KW - ventricular tachycardia
KW - SBRT
KW - STAR
KW - cardiac radioablation
KW - personalized medicine
KW - radiosurgery
KW - radiotherapy
KW - ventricular arrhythmia
KW - ventricular tachycardia
UR - http://hdl.handle.net/10807/198601
U2 - 10.3389/fcvm.2020.565471
DO - 10.3389/fcvm.2020.565471
M3 - Article
SN - 2297-055X
VL - 7
SP - 565471-N/A
JO - Frontiers in Cardiovascular Medicine
JF - Frontiers in Cardiovascular Medicine
ER -